Frazier Life Sciences Closes $987 Million Venture Fund to Invest in Companies Developing Novel Biopharmaceuticals
Frazier Life Sciences announced today the closing of Frazier Life Sciences XI, L.P. ("FLS XI"), exceeding its target of $800 million and raising more than $987 million in capital commitments in an oversubscribed